SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ
SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ
复制标题
DOI:
10.1182/blood-2011-04-347930
复制
发表时间:
2011-07-28
期刊:
影响因子:
20.3
通讯作者:
Vinkemeier, Uwe
中科院分区:
文献类型:
--
作者:
Begitt, Andreas;Droescher, Mathias;Vinkemeier, Uwe
The biologic effects of IFN gamma are mediated by the transcription factor STAT1. The activity of STAT1 is inhibited by small ubiquitin-like modifier (SUMO) conjugation. This occurs both directly through decreasing STAT1 tyrosine phosphorylation and indirectly by facilitating STAT1 dephosphorylation consequential to increased STAT1 solubility because of suppressed paracrystal assembly. However, the physiologic implications of SUMO conjugation have remained unclear. Here, we used fibroblasts and bone marrow-derived macrophages (BMMs) from knockin mice expressing SUMO-free STAT1 to explore the consequences of STAT1 sumoylation for IFN gamma signaling. Our experiments demonstrated buffer property of paracrystals for activated STAT1, such that SUMO-mediated paracrystal dispersal profoundly reduced phosphorylation of STAT1, which affected both the activating tyrosine 701 and the transcription-enhancing serine 727. Accordingly, the curtailed STAT1 activity in the nucleus caused by SUMO conjugation resulted in diminished transcription of IFN gamma responsive genes; and increased the IFN gamma concentration more than 100-fold required to trigger lipopolysaccharide-induced cytotoxicity in bone marrow-derived macrophages. These experiments identify SUMO conjugation of STAT1 as a mechanism to permanently attenuate the IFN gamma sensitivity of cells, which prevents hyperresponsiveness to this cytokine and its potentially self-destructive consequences. This sets the mode of SUMO-mediated inhibition apart from the other negative STAT regulators known to date. (Blood. 2011; 118(4): 1002-1007)